🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2, Dose-ranging, 12-week Randomized, Double-blind, Placebo controll...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U
Start Date
2016-10
Trial ID
NCT02967510
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
This randomized phase II trial studies the side effects of durvalumab and t...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2017-08-14
Trial ID
NCT02888743
Treatments Being Tested
patients with previous failed ART cycles with high peripheral NK cells will...
Status
Completed
Location
Banha University- Hawaa Fertility center
Start Date
2019-01-01
Trial ID
NCT03792997
Treatments Being Tested
The overall objective of this study is to assess the safety and efficacy of...
Status
Completed
Location
Research Facility
Start Date
2008-12
Trial ID
NCT00713310
Treatments Being Tested
The purpose of this study is to assess safety, tolerability, preliminary ef...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09-25
Trial ID
NCT04464460
Treatments Being Tested
Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biol...
Status
Completed
Location
ZGT hospital
Start Date
2016-03
Trial ID
NCT02602925
Treatments Being Tested
This study will test the safety and effectiveness of using lower-dose ritux...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-08-10
Trial ID
NCT00366418
Treatments Being Tested
This open-label, prospective, single-arm, multicenter study will evaluate t...
Status
Completed
Location
Canberra Hospital
Start Date
2012-06-26
Trial ID
NCT01588990
Treatments Being Tested
Combined modality approach using Obitunuzumab and involved site low dose ir...
Status
Completed
Location
University of Tuebingen
Start Date
2018-04-24
Trial ID
NCT03341520
Treatments Being Tested